T. F. Vroom

Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil.

F. V. van’t Hooft, A. Van der Laarse, A. Smelt, 1994, The American journal of medicine.

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.

F. H. Man, A. Van der Laarse, L. Havekes, 2000, Atherosclerosis.

Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin.

A. Van der Laarse, R. Frants, L. Havekes, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.